These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39287441)

  • 1. Alterations in circulating immunoregulatory proteins discriminate poor CD4 T lymphocyte trajectories in people with HIV on suppressive antiretroviral therapy.
    Moar P; Bowler S; Landay AL; Gianella S; Ndhlovu LC; Premeaux TA
    mBio; 2024 Oct; 15(10):e0226524. PubMed ID: 39287441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy.
    Scherpenisse M; Kootstra NA; Bakker M; Berkhout B; Pasternak AO
    mBio; 2021 Mar; 12(2):. PubMed ID: 33688002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy.
    Chiu CY; Schou MD; McMahon JH; Deeks SG; Fromentin R; Chomont N; Wykes MN; Rasmussen TA; Lewin SR
    Front Immunol; 2023; 14():1123342. PubMed ID: 37056754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
    Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
    J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographic and clinical factors correlated with clinical outcomes among people with HIV treated by antiretroviral therapy: a retrospective cohort study.
    Li Y; Liu H; Zhang S; Zhang Y; Wang H; Zhang H; Li X
    BMC Infect Dis; 2024 May; 24(1):514. PubMed ID: 38778273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals.
    Okulicz JF; Le TD; Agan BK; Camargo JF; Landrum ML; Wright E; Dolan MJ; Ganesan A; Ferguson TM; Smith DM; Richman DD; Little SJ; Clark RA; He W; Ahuja SK
    JAMA Intern Med; 2015 Jan; 175(1):88-99. PubMed ID: 25419650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy.
    Jiang W; Luo Z; Martin L; Wan Z; Fu P; Wagner A; Ling B; Heath SL; Haque A; McRae-Clark A
    Curr HIV Res; 2018; 16(2):143-150. PubMed ID: 29968539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases.
    Baker JV; Peng G; Rapkin J; Krason D; Reilly C; Cavert WP; Abrams DI; MacArthur RD; Henry K; Neaton JD;
    J Acquir Immune Defic Syndr; 2008 Aug; 48(5):541-6. PubMed ID: 18645520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia.
    Wolday D; Legesse D; Kebede Y; Siraj DS; McBride JA; Striker R
    PLoS One; 2020; 15(10):e0240880. PubMed ID: 33091053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the gut microbiome in HIV infection highlight human anelloviruses as potential predictors of immune recovery.
    Boukadida C; Peralta-Prado A; Chávez-Torres M; Romero-Mora K; Rincon-Rubio A; Ávila-Ríos S; Garrido-Rodríguez D; Reyes-Terán G; Pinto-Cardoso S
    Microbiome; 2024 Oct; 12(1):204. PubMed ID: 39420423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between recent thymic emigrants and CD4+ T-cell recovery after short-term antiretroviral therapy initiation.
    Briceño O; Chávez-Torres M; Peralta-Prado A; Garrido-Rodríguez D; Romero-Mora K; Pinto-Cardoso S; Reyes-Terán G
    AIDS; 2020 Mar; 34(4):501-511. PubMed ID: 31794524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of rare HIV-1-infected patients with extreme CD4+ T cell decline despite ART-mediated viral suppression.
    Lisco A; Wong CS; Lage SL; Levy I; Brophy J; Lennox J; Manion M; Anderson MV; Mejia Y; Grivas C; Mystakelis H; Burbelo PD; Perez-Diez A; Rupert A; Martens CA; Anzick SL; Morse C; Chan S; Deleage C; Sereti I
    JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents.
    Krogstad P; Patel K; Karalius B; Hazra R; Abzug MJ; Oleske J; Seage GR; Williams PL; Borkowsky W; Wiznia A; Pinto J; Van Dyke RB;
    AIDS; 2015 Mar; 29(6):683-93. PubMed ID: 25849832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery.
    Gómez-Mora E; Massanella M; García E; Giles D; Bernadó M; Urrea V; Carrillo J; Ouchi D; Puig J; Negredo E; Clotet B; Blanco J; Cabrera C
    PLoS One; 2017; 12(9):e0184433. PubMed ID: 28934217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
    Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR
    J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced immune reconstitution with albuvirtide in HIV-infected immunological non-responders.
    Fan L; Hu Y; Li R; Ding J; Liu Y; Yu S; Hu M; Su R; Li Y; Yu A; Xie D; Zhao Q; Ma P
    Front Cell Infect Microbiol; 2024; 14():1397743. PubMed ID: 38975330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Risk Factors Associated With Poor Quality of Sleep in People Living with HIV and the Correlation between Quality of Sleep and Cd4+ T Lymphocyte Reconstitution: A Cross-Sectional Study from Turkey.
    Korkmaz OE; Aydoğmuş FK
    Curr HIV Res; 2024; 22(3):202-211. PubMed ID: 38747228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort.
    Nakanjako D; Ssewanyana I; Mayanja-Kizza H; Kiragga A; Colebunders R; Manabe YC; Nabatanzi R; Kamya MR; Cao H
    BMC Infect Dis; 2011 Feb; 11():43. PubMed ID: 21299909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic and Virologic Parameters Associated With Human Immunodeficiency Virus (HIV) DNA Reservoir Size in People With HIV Receiving Antiretroviral Therapy.
    Blazkova J; Whitehead EJ; Schneck R; Shi V; Justement JS; Rai MA; Kennedy BD; Manning MR; Praiss L; Gittens K; Wender PA; Oguz C; Lack J; Moir S; Chun TW
    J Infect Dis; 2024 Jun; 229(6):1770-1780. PubMed ID: 38128541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.